June 05, 2023 / 09:46 IST
Reported Standalone quarterly numbers for Bharat Immunologicals and Biologicals Corporation are:Net Sales at Rs 7.65 crore in March 2023 down 65.29% from Rs. 22.04 crore in March 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 4.29 crore in March 2023 down 333.76% from Rs. 0.99 crore in March 2022.
EBITDA stands negative at Rs. 4.17 crore in March 2023 down 37.62% from Rs. 3.03 crore in March 2022.
Bharat Immuno shares closed at 22.69 on June 02, 2023 (BSE) and has given -20.94% returns over the last 6 months and -17.64% over the last 12 months.
| Bharat Immunologicals and Biologicals Corporation | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'23 | Dec'22 | Mar'22 | | Net Sales/Income from operations | 7.65 | -- | 22.04 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 7.65 | -- | 22.04 | | EXPENDITURE | | Consumption of Raw Materials | 0.00 | 6.51 | 4.90 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 7.84 | -7.83 | 14.97 | | Power & Fuel | -- | -- | -- | | Employees Cost | 3.31 | 4.10 | 4.77 | | Depreciation | 0.04 | 0.04 | 0.06 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 2.90 | 1.95 | 0.95 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -6.45 | -4.76 | -3.60 | | Other Income | 2.24 | 0.10 | 0.51 | | P/L Before Int., Excpt. Items & Tax | -4.21 | -4.66 | -3.09 | | Interest | 2.05 | 1.67 | 1.67 | | P/L Before Exceptional Items & Tax | -6.26 | -6.33 | -4.76 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -6.26 | -6.33 | -4.76 | | Tax | -1.97 | -1.65 | -3.77 | | P/L After Tax from Ordinary Activities | -4.29 | -4.68 | -0.99 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -4.29 | -4.68 | -0.99 | | Equity Share Capital | 43.18 | 43.18 | 43.18 | | Reserves Excluding Revaluation Reserves | 44.62 | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.99 | -1.08 | -0.23 | | Diluted EPS | -- | -1.08 | -- | | EPS After Extra Ordinary | | Basic EPS | -0.99 | -1.08 | -0.23 | | Diluted EPS | -- | -1.08 | -- | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
